35
Views
25
CrossRef citations to date
0
Altmetric
Review

Antimalarial peroxides in the qinghaosu (artemisinin) and yingzhaosu families

Pages 1487-1493 | Published online: 25 Feb 2005

Bibliography

  • TDR News (News from the WHO Division of Control of Tropical Diseases). (1994) 46:5.
  • The New York Times. A rare case of malaria is reported in Virginia. (August 2, 1998):23.
  • RIDLEY RG, HUDSON AT: Quinoline antimalarials. Exp. Opin. Ther. Patents (1998) 8 (2) :121–136.
  • ••An excellent recent review on quinoline-basedantimalarials.
  • PETERS W: Chemotherapy and Drug Resistance in Malaria (Second Edition). Academic Press, London (1987).
  • HOFFMANN SL: Artemether in severe malaria - still too many deaths. New Engl. J. Med. (1996) 335:124–126.
  • CUMMING JN, PLOYPRADITH P, POSNER GH: Antimalar-ial activity of artemisinin (qinghaosu) and related tri-oxanes: mechanism(s) of action. Adv. Pharmacol. (1997) 37:253–297.
  • ••A comprehensive review from a chemical viewpoint.
  • MESHNICK SR, TAYLOR TE, KAMCHONWONGPAISAN S: Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Micro-bic)]. Rev. (1996) 60:301–315.
  • ••An authoritative review from a biomedical perspective.
  • POSNER GH, OH CH: A regiospecifically labeled 1,2,4-trioxane: a simple chemical model system to probe the mechanism(s) for the antimalarial activity of artemisi-nin (qinghaosu). J. Am. Chem. Soc. (1992) 114:8328–8329.
  • ••This is the first report of a carbon-centred radical intermedi-ate from an antimalarial peroxide.
  • ROBERT A, MEUNIER B: Alkylating properties of antimalarial artemisinin derivatives and synthetic triox-anes activated by a reduced heme model. Chem. Eur. J. (1998) 4:1287–1296.
  • •This is the first full report of isolating a covalent adduct formed between a porphyrin and a peroxide-derived carbon-centred radical.
  • ZHOU W-S, XU XX: Total synthesis of the antimalarial sesquiterpene peroxide qinghaosu and yingzhaosu A. Acc. Chem. Res. (1994) 27:211–216.
  • JAQUET C, STOHLER HR, CHOLLET J, PETERS W: Antima-larial activity of the bicyclic peroxide Ro 42-1611 (ar-teflene) in experimental models. Trop. Med. Parasitol. (1994) 45:266–271.
  • BACHI MD, KORSHIN E, PLOYPRADITH P etal.: Synthesis and in vitro antimalarial activity of sulfone endoper-oxides. Bioorg. Med. Chem. Lett. (1998) 8:903–906.
  • MASCIADRI R, HUBSCHWERLEN C: Personal communica-tion. (February 6, 1998).
  • BACHI MD, KORSHIN E, PLOYPRADITH P et al: Thiol-oxygen co-oxidation of monoterpenes. Synthesis of endoperoxides structurally related to antimalarial yingzhaosu A. Synlett (1998) 122–125.
  • •Short and effective synthesis of antimalarial endoperoxides.
  • O'NEILL PM, SEARLE NL, RAYNES KJ eta].: A carbonyl ox-ide route to antimalarial yingzhaosu A analogues: syn-thesis and antimalarial activity. Tetrahedron Lett. (1998) 39:6065–6068.
  • BACHI MD, KORSHIN EE, POSNER GH: Novel antimalarial compounds. (1998)
  • •A patent application has been filed.
  • POSNER GH, O'DOWD H, PLOYPRADITH P, CUMMING JN, XIE S, SHAPIRO TA: Antimalarial cyclic peroxy ket-als. J. Med. Chem. (1998) 41:2164–2167.
  • HIEN TT, WHITE NJ: Qinghaosu. Lancet (1993) 341:603–608.
  • ZIFFER H, HIGHET RJ, KLAYMAN DL: Artemisinin: an en-doperoxidic antimalarial from artemisia annua L. Prog. Chem. Org. Nat. Prod. (1997) 72:123–124.
  • ••An excellent comprehensive review of this field.
  • HAYNES RK, VONWILLER SC: From qinghao, marvellous herb of antiquity, to the antimalarial trioxane qing-haosu - and some remarkable new chemistry. Acc. Chem. Res. (1997) 30:73.
  • HALPAP B, NDJAVE M, PARIS M, BENAKIS A, KREMSNER PG: Plasma levels of artesunate and dihydroartemisi-nin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesu-nate suppositories. Am. J. Trop. Med. Hyg. (1998) 58:365–368.
  • UN AJ, ZIKRY AB, KYLE DE: Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-Substituted phenyl)-4(R or 5)-L10 (a or 6)-dihydroartemisin-inoxylbutyric acids. J. Med. Chem. (1997) 40:1396–1400.
  • BREWER TG, GRATE SJ, PEGGINS JO et al: Fatal neuro-toxicity of arteether and artemether. Am. J. Trop. Med. Hyg. (1994) 51:251–259.
  • KAMCHONWONGPAISAN S, MCKEEVER P, HOSSLER P, ZIFFER H, MESHNICK SR: Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vi-tro. Am. J. Trop. Med. Hyg. (1997) 56:7–12.
  • ABOUABDELLAH A, BÉGUR J-P, BONNET-DELPON D, GANTIER J-C, NGA, TTT, THAC TD: Synthesis and in vivo antimalarial activity of 12a-trifluoromethylhydroarte-misinin. Bioorg. Med. Chem. Lett. (1996) 6:2717–2720.
  • HAYNES RK, VONWILLER SC: Efficient preparatory of novel qinghaosu (artemisinin) derivatives: conver-sion of qinghao (artemisinic) acid into deoxoqing-haosu derivatives and 5-carba-4-deoxoartesunic acid. Synlett (1992) 481–483.
  • PU YM, ZIFFER H: Synthesis and antimalarial activities of 126-allyldeoxoartemisinin and its derivatives. J. Med. Chem. (1995) 38:613–616.
  • JUNG M, LEE S: A concise synthesis of novel aromaticanalogs of artemisinin. Heterocycles (1997) 45:1055–1057.
  • WOO SH, PARKER MH, PLOYPRADITH P, NORTHROP J,POSNER GH: Direct conversion of pyranose anomeric OH - F - R in the artemisinin family of antimalarial trioxanes. Tetrahedron Lett. (1998) 39:1533–1536.
  • JUNG M, LEE S: Stability of acetal and nonacetal-type analogs of artemisinin in simulated stomach acid. Bioorg. Med. Chem. Lett. (1998) 8:1003–1006.
  • POSNER GH, PARKER MH, NORTHROP J et al.: Orally ac-tive, hydrolytically stable, semi-synthetic antimalarial trioxanes in the artemisinin family. J. Med. Chem. (1999) 42. (In Press).
  • ••Full details on synthesis of C-10-non-acetal derivatives of10-deoxoartemesinin.
  • POSNER GH, WOO SH, PLOYPRADITH P et al.: C-10 carbon-substituted artemisinin-like trioxane com-pounds having antimalarial, antiproliferative and an-titumor activities. (1998).
  • •A patent application has been filed. See also Bioorg. Med. Chem. (1997) 5:1257–1265.
  • BEEKMAN AC, BARENTSEN ARW, WOERDENBAG HJ et al.:Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. J. Nat. Prod. (1997) 60:325–330.
  • PETERS W, ROBINSON BL, TOVEY G, ROSSIER JC, JEF-FORD CW: The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant para-sites. Part 3: observations on `fenozan-50f, a difluori-nated 3,3'-spirocyclopentane 1,2,4-trioxane. Ann. Trop. Med. Parasit. (1993) 87:111–123.
  • FLECK SL, ROBINSON BL, PETERS W et al.: The chemo-therapy of rodent malaria. LIII. `fenozan b07' (fenozan 50f), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. Am. Trop. Med. Hyg. (1997) 91:25–32.
  • POSNER GH, OH CH, GERENA L, MILHOUS WK: Extraor-dinarily potent antimalarial compounds: new, struc-turally simple, easily synthesized, tricyclic 1,2,4-trioxanes. J. Med. Chem. (1992) 35:2459–2467.
  • POSNER GH, OH CH, WEBSTER K, AGER AL, JR., ROSSAN RN: New, antimalarial, tricyclic 1,2,4-trioxanes: pre-clinical evaluation in mice and monkeys. Am. J. Trop. Med. Hyg. (1994) 50:522–526.
  • POSNER GH, CUMMING JN, WOO SH, PLOYPRADITH P, XIE S, SHAPIRO TA: Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation. J. Med. Chem. (1998) 41:940–951.
  • POSNER GH, CUMMING JN, WOO SH: C-3 substituted tri-oxanes useful as antiparasitic drugs. (1998).
  • •A patent application has been filed.
  • VENNERSTROM JL, FU HN, ELLIS WY et al.: Dispira-1,2,4,5-tetraoxanes: a new class of antimalar-ial peroxides. J. Med. Chem. (1992) 35:3023–3027.
  • TODORSVIC NM, STEFANOUIC M, TINANT B, DECLEREQ JP, MAKLER MT, SOLAJA BA: Steroidal geminal dihy-droepoxides and 1,2,4,5-tetraoxanes: structure and de-termination of antimalarial activity. Steroids (1996) 61:688–696.
  • VON SEIDLIN L, JAFFAR S, PINDER M et al.: Treatment of African children with uncomplicated falciparum ma-laria with a new antimalarial drug, cgp 56697.1 Inf. Dis. (1997) 176:1113–1116.
  • LOOAREESUVAN S, WILAIRATANA P, VANIGANONTA S, VIRAVAN C, ANDRIAL M: Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment. Am. Trop. Med. Parasitol. (1995) 89:469–475.
  • GOMEZ LANDIRES EA: Efficacy of artesunate supposi-tory followed by oral mefloquine in the treatment of severe falciparum malaria in endemic areas where re-sistance to chloroquine exists in Ecuador. Jpn. J. Trop. Med. Hyg. (1996) 24:17–24.
  • PRICE RN, NOSTEN F, LUXEMBURGER C et al: Artesu-nate/mefloquine treatment of multidrug resistant fal-ciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (1997) 91:574–577.
  • SABCHRAREON A, ATTANATH P, CHARTHAVANICH P et al.: Comparative clinical trial of artesunate supposito-ries and oral artesunate in combination with meflo-quine in the treatment of children with acute falciparum malaria. Am. J. Trop. Med. Hyg. (1998) 58:11–16.
  • ••Excellent dose regimen discussion plus background refer-ences to artesunate development.
  • HARALDSON CA, KARLE JM, FREEMAN SG, DUVADIE RK, AVERY MA: The synthesis of 8,8-disubstituted tricyclic analogs of artemisinin. Bioorg. Med. Chem. Lett. (1997) 7:2357–2362.
  • AVERY MT, ALVIM-GASTON M, WOOLFREY JR: Synthesis and structure-activity relationships of peroxidic anti-malarials based on artemisinin. Adv. Med. Chem. (1998) (In Press).
  • ••A comprehensive summary of the Avery group's major con-tributions in this area.
  • WILLIAMS N: Tropical diseases: drug companies decline to collaborate. Science (1997) 278:1704.
  • •Discussion of a missed opportunity to support development of new malaria therapies.
  • COREY J: A fresh shot at malaria. Business Week (Sept. 21, 1998)70–73.
  • PATZ JA, EPSTEIN PR, BURKE TA, BALBUS JM: Global cli-mate change and emerging infectious diseases. J. Am. Med. Assoc. (1996) 275:217–223.
  • •A scholarly and authoritative update on global warming.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.